Soleno Therapeutics (SLNO) Cash & Equivalents Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.17% |
| Dec 31, 2025 | 7.33% |
| Sep 30, 2025 | 34.45% |
| Jun 30, 2025 | 4.12% |
| Mar 31, 2025 | 40.10% |
| Dec 31, 2024 | 33.50% |
| Sep 30, 2024 | 33.95% |
| Jun 30, 2024 | 29.76% |
| Mar 31, 2024 | 17.14% |
| Dec 31, 2023 | 49.01% |
| Sep 30, 2023 | 38.62% |
| Jun 30, 2023 | 8.99% |
| Mar 31, 2023 | -11.88% |
| Dec 31, 2022 | -3.11% |
| Sep 30, 2022 | 255.06% |
| Jun 30, 2022 | 269.37% |
| Mar 31, 2022 | 283.41% |
| Dec 31, 2021 | 50.86% |
| Sep 30, 2021 | 39.09% |
| Jun 30, 2021 | 68.11% |
| Mar 31, 2021 | 45.00% |
| Dec 31, 2020 | 55.04% |
| Sep 30, 2020 | 64.08% |
| Jun 30, 2020 | 52.69% |
| Mar 31, 2020 | 9.60% |
| Dec 31, 2019 | 21.11% |
| Sep 30, 2019 | 181.06% |
| Jun 30, 2019 | 66.60% |
| Mar 31, 2019 | 90.96% |
| Dec 31, 2018 | 78.67% |
| Sep 30, 2018 | 38.74% |